Holland & Knight advised DifGen Pharmaceuticals LLC on its all-cash purchase, through its subsidiary Aveva Drug Delivery Systems Inc., of the operating and manufacturing assets of a U.S. Food and Drug Administration (FDA)-registered manufacturing facility owned by New Vision Pharmaceuticals and located in Tamarac, Florida. The transaction was closed on March 18.

The facility has state-of-the-art manufacturing capability to handle solutions/suspension/emulsions through blow-fill-seal, form-fill-seal technology and traditional filling of liquid and semi-solid products in a variety of dosage forms, including stick packs and unit-dose cups.

DifGen, based in Princeton, New Jersey, is a global pharmaceutical company with a primary focus on developing and manufacturing complex, high-barrier-to-entry generics and specialty pharmaceutical products that would help increase accessibility to high-quality medication, thereby leading to the creation of next generation healthy communities.